NCT04124406View on ClinicalTrials.gov

Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality

Active, not recruitingOBSERVATIONAL

Enrollment

150,000

Participants

Timeline

Start Date

October 18, 2019

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2025

Conditions

Colon Cancer

Interventions

DEVICE

Cologuard

multi-target stool Deoxyribonucleic Acid (MT-sDNA) screening test

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Exact Sciences Corporation

Collaborators (1)

All Listed Sponsors

collaborator

Mayo Clinic

OTHER

lead

Exact Sciences Corporation

INDUSTRY